Second Xarelto Bellwether Trial Win by the Defendants
On June 12, 2017, a New Orleans federal jury awarded a defense verdict to Bayer and Janssen in the second bellwether trial in 15,000-case litigation over severe health complications allegedly caused by their drug Xarelto. This is the second time the drug manufacturers win in the multi-district litigation.
There are two more trials scheduled in Federal Court in New Orleans, with the third one being set for August 2017.
For more information about this trial read this article by Reuters.